首页 > 市场调查报告书 > 製药

医药品原料药

市场调查报告书

商品编码

1935378

小分子原料药市场：依原料药类型、应用与地区划分

Small Molecule API Market, By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

出版日期: 2026年01月21日 | 出版商:

Coherent Market Insights | 英文 154 Pages | 商品交期: 2-3个工作天内

价格

简介目录

预计到 2026 年，小分子原料药市场规模将达到 1,304 亿美元，到 2033 年将达到 1,774 亿美元，2026 年至 2033 年的复合年增长率为 4.5%。

报告内容		报告详情
基准年：	2025	2026年市场规模：	1304亿美元
历史数据时期：	2020年至2024年	预测期：	2026年至2033年
预测期（2026-2033年）复合年增长率：	4.50%	2033 年的预测值：	1774亿美元

小分子活性药物成分（API）是分子量较低的有机化合物，可能有助于调节生物过程。大多数小分子化合物可口服给药，且容易被人体吸收。其小分子尺寸使其能够快速扩散并到达细胞内的作用位点。

市场动态

亚太地区小分子原料药生产商的扩张是推动小分子原料药市场成长的主要因素。例如，BASF计划在其位于中国南京化工园区的现有厂址新建一座特种胺工厂。这座新的多产品工厂年产能将达到2.1万吨胺类化合物，并将扩大BASF南京特种胺生产基地的胺类产品组合。该工厂预计将于2019年运作。此外，随着全球销售和业务拓展部门的扩张，小分子原料药生产商计划扩充其品管、法规事务和计划管理团队，这也将对市场成长产生积极影响。

然而，严格的原料药生产监管政策可能会阻碍市场成长。全球范围内针对小分子原料药生产品质评估、设施认证以及新兴国家日益严峻的供应链安全问题的严格监管政策，显着影响了最终小分子原料药产品的成本。由于上述因素，有意进入小原料药生产市场的新企业面临巨大的财务挑战。

本次调查的主要特点

本报告对小分子原料药市场进行了详细分析，以 2025 年为基准年，给出了预测期（2026-2033 年）内的市场规模（十亿美元）和復合年增长率（%）。
我们将重点介绍各个细分市场的潜在商机，并说明该市场具有吸引力的投资提案矩阵。
该研究还提供了有关市场驱动因素、限制因素、机会、影响分析、PEST 分析、合作关係、併购、监管环境、技术进步、小分子 API 的生产流程、主要供应商和市场趋势的关键见解。
该研究根据以下参数对全球小分子API市场的主要企业进行了分析：公司概况、财务业绩、产品系列、市场地位、分销策略、关键发展、战略和未来计划。
本报告的研究结果将使负责人和企业经营团队能够就即将推出的产品、技术升级、市场扩张和行销策略做出明智的决策。
这份全球小分子原料药市场报告的目标受众是业内各类相关人员，包括投资者、供应商、产品製造商、经销商、新参与企业和金融分析师。
相关人员可以透过各种用于分析小分子原料药市场的策略矩阵轻鬆做出决策。

北美洲
- 我们
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲国家
欧洲
- 英国
- 德国
- 义大利
- 法国
- 西班牙
- 俄罗斯
- 其他欧洲
亚太地区
- 中国
- 印度
- 日本
- ASEAN
- 澳洲
- 韩国
- 亚太其他地区
中东
- 海湾合作委员会国家
- 以色列
- 其他中东国家
非洲
- 南非
- 北非
- 中非

第七章竞争情势

热图分析
市占率分析（3x3矩阵）
公司简介
- ALLERGAN
- Aurobindo Pharma
- Cambrex Corporation
- Albemarle Corporation
- Dr Reddy's Laboratories Ltd.
- Johnson Matthey
- Siegfried Holding AG
- Pfizer
- Sanofi SA
- Novartis AG
- Johnson &Johnson
- Bristol-Myers Squibb
- Bachem Holding AG
- Boehringer Ingelheim GmbH
- F. Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- GILEAD Science Inc.
- Albany Molecular Research Inc.
- Sun Pharmaceuticals
- AstraZeneca
- Merck &Co, Inc.
- BASF SE
- Teva Pharmaceuticals

第八章分析师建议

机会
分析师观点
Coherent Opportunity Map

第九章各节

参考
调查方法

简介目录

Product Code: CMI2423

Small Molecule Api Market is estimated to be valued at USD 130.4 Bn in 2026 and is expected to reach USD 177.4 Bn by 2033, growing at a compound annual growth rate (CAGR) of 4.5% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 130.4 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	4.50%	2033 Value Projection:	USD 177.4 Bn

A small molecule Active Pharmaceutical Ingredient (API) is a low molecular weight organic compound, which may help to control biological process. Most of the small molecules can be administered orally and are most likely to be absorbed by the body. Owing to its small size it has properties of rapid diffusibility to reach the intracellular site of action.

Market Dynamics

Growing expansion of small molecule API manufacturers in the Asia Pacific region is a major factor driving the small molecule API market growth. For instance, BASF is planning to build a new specialty amines plant at its existing site in Nanjing Chemical Industry Park, China. This new multi-product plant will be able to manufacture 21,000 metric tons of amines year, and it extends BASF's amines portfolio at the specialty amines complex in Nanjing. The plant is scheduled to stream by 2019. Moreover the small molecule API manufacturers have planned to add global sales and business development staff, followed by quality, regulatory, and project management teams, which have positively influenced growth of the market.

However, stringent regulatory policies for API manufacturing may hinder the market growth. Stringent global regulatory policies on quality assessments of small molecule API manufacturing, facility certification, and increased supply chain security issues across emerging countries have a large impact on the cost of final small molecule API products. The new entrants willing to enter into small molecule API manufacturing are facing financial challenges, owing to aforementioned factors.

Key features of the study

This report provides in-depth analysis of the small molecule API market and provides market size (USD Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2026 - 2033), considering 2025 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, impact analysis, PEST analysis, collaborations, mergers and acquisitions, regulatory scenarios, technological advancements, steps to manufacture small molecule API, major suppliers of small molecule APIs, market trends
It profiles key players in the global small molecule API market based on the following parameters - company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include, Lonza, Sanofi S.A., Sun Pharmaceutical Industries Ltd., Teva Pharmaceutical Industries Ltd., Pfizer, Inc., Aesica Pharmaceuticals Ltd., Albemarle Corporation, Cambrex Corporation, BASF SE, Gland Pharma Limited, Gilead Sciences, Inc., AstraZeneca Plc, Baxter International Inc., Boehringer Ingelheim International GmbH, Celgene Corporation, Piramal Pharma Solutions, Recipharm AB, Evonik Industries AG, Glenmark Pharmaceuticals Limited, Siegfried AG, AbbVie Contract Manufacturing, Aurinia Pharmaceuticals Inc., Bayer AG, Patheon, CordenPharma International
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, technology up-gradation, market expansion, and marketing tactics.
The global small molecule API market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the small molecule API market

Market Segmentation

API Type Insights (Revenue, USD Bn, 2026 - 2033)
- Synthetic
- Biological
Application Insights (Revenue, USD Bn, 2026 - 2033)
- Oncology
- Neurology
- Metabolic
- Infectious
- Cardiovascular
Regional Insights (Revenue, USD Bn, 2026 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
- ALLERGAN
- Aurobindo Pharma
- Cambrex Corporation
- Albemarle Corporation
- dr. Reddy's Laboratories Ltd.
- Johnson Matthey
- Siegfried Holding AG
- Pfizer
- Sanofi S.A.
- Novartis AG
- Johnson & Johnson
- Bristol-Myers Squibb
- Bachem Holding AG
- Boehringer Ingelheim GmbH
- Hoffmann-La Roche Ltd
- GlaxoSmithKline PLC
- GILEAD Science Inc.
- Albany Molecular Research Inc.
- Sun Pharmaceuticals
- AstraZeneca
- Merck & Co, Inc.
- BASF SE
- Teva Pharmaceuticals

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By API Type
- Market Snippet, By Application
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- PEST Analysis
- PORTER's Five Forces Analysis
- Market Opportunities
- Regulatory Scenario
- Key Developments
- Industry Trend

4. Global Small Molecule API Market, By API Type, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Synthetic
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Biological
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

5. Global Small Molecule API Market, By Application, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Oncology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Neurology
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Metabolic
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Infectious
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends
Cardiovascular
- Market Share Analysis, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, 2021 - 2033
- Segment Trends

6. Global Small Molecule API Market, By Region, 2026-2033, (USD Bn)

Introduction
- Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
- Y-o-Y Growth Analysis, For Region, 2021 - 2033
North America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.S.
  - Canada
Latin America
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
- Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
- Market Size and Forecast, By API Type, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Application, 2026- 2033, (USD Bn)
- Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

7. Competitive Landscape

Heat Map Analysis
Market Share Analysis (3x3 Matrix)
Company Profiles
- ALLERGAN
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Aurobindo Pharma
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Cambrex Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Albemarle Corporation
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- D.r. Reddy's Laboratories Ltd.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson Matthey
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Siegfried Holding AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Pfizer
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sanofi S.A.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Novartis AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Johnson & Johnson
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bristol-Myers Squibb
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Bachem Holding AG
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Boehringer Ingelheim GmbH
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- F. Hoffmann-La Roche Ltd
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GlaxoSmithKline PLC
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- GILEAD Science Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Albany Molecular Research Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Sun Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- AstraZeneca
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Merck & Co, Inc.
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- BASF SE
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates
- Teva Pharmaceuticals
  - Company Overview
  - Product Type Portfolio
  - Recent Developments/Updates

8. Analyst Recommendation

Wheel of Fortune
Analyst View
Coherent Opportunity Map

9. Section

References
Research Methodology
About Us and Sales Contact

02-2729-4219

+886-2-2729-4219

License/价格

小分子原料药市场：依原料药类型、应用与地区划分

Small Molecule API Market, By API Type (Synthetic and Biological), By Application (Oncology, Neurology, Metabolic, Infectious, and Cardiovascular), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

市场动态